Academic Journal

A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years

التفاصيل البيبلوغرافية
العنوان: A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years
المؤلفون: Craig I. Coleman Pharma D, FASHP, FACC, Olivia S. Costa PharmD, Christopher W. Brescia BS, Burcu Vardar MD, Khaled Abdelgawwad MSc, Lucas Hofmeister PhD, Nitesh Sood MD
المصدر: Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
بيانات النشر: SAGE Publishing, 2022.
سنة النشر: 2022
المجموعة: LCC:Diseases of the circulatory (Cardiovascular) system
مصطلحات موضوعية: Diseases of the circulatory (Cardiovascular) system, RC666-701
الوصف: Background Advanced age and type 2 diabetes (T2D) are common in patients with nonvalvular atrial fibrillation (NVAF). We evaluated the impact of age on the effectiveness and safety of rivaroxaban versus warfarin in this population. Methods We analyzed electronic health record data from November 2010, to December 2019 including adults with NVAF and T2D, newly started on rivaroxaban or warfarin. Propensity score-overlap weighted hazard ratios (HRs) for stroke/systemic embolism (SSE), hospitalization for major or clinically relevant nonmajor bleeding (CRNMB), vascular death, major adverse limb events (MALE), major bleeding, and intracranial hemorrhage (ICH) were calculated for older (≥80 years) and younger (
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1938-2723
10760296
Relation: https://doaj.org/toc/1938-2723
DOI: 10.1177/10760296221133083
URL الوصول: https://doaj.org/article/30a9a9056db54131b436e77329ceb625
رقم الانضمام: edsdoj.30a9a9056db54131b436e77329ceb625
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:19382723
10760296
DOI:10.1177/10760296221133083